Delivery Order SPE2DB20D2104-SPE2DB25FMYAM
- Not listed
- The Defense Logistics Agency awarded a $2,997.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by April 25, 2025, with performance...
- The Defense Logistics Agency awarded a $2,015.65 delivery order to AmerisourceBergen Drug Corp for Trulicity 4.5 mg/0.5 ml pen (0.5 ml), a diabetes medication, on August 8, 2025, with completion expected by August 11, 2025. This is a firm fixed price, non-set-aside contract with performance at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger relationship with the federal...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,663.27 for Trulicity 1.5 mg/0.5 ml pen 0.5ml, a diabetes medication, with an ultimate completion date of August 13, 2025. This non-competitive, firm fixed-price delivery order was awarded on August 12, 2025, with performance to be executed at the vendor's location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a $2,402.40 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 0.75 mg/0.5 ml pen injections on July 18, 2025, with completion targeted for July 21, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $1,878.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 mL pen injectors (0.5 mL units) on August 19, 2025, with completion scheduled for August 20, 2025. This competitive award, with no set-aside designation, represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at approximately $1 billion through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $5,050.63 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pen injectors on August 18, 2025, with completion targeted for August 19, 2025. The contract employs firm fixed pricing under a non-competitive delivery order structure and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $1,628.68 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections with an ultimate completion date of August 19, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award to a qualified vendor. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $5,555.55 delivery order to AmerisourceBergen Drug Corp for Trulicity 1.5 mg/0.5 ml pen injectors on September 17, 2025, with an ultimate completion date of September 18, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The work will be performed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pens valued at $8,764.26. This is a firm fixed price, non-competitive delivery order with an ultimate completion date of September 22, 2025, and performance to be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,277.30 for Trulicity 1.5 mg/0.5 mL pen injections on April 24, 2025, with an ultimate completion date of April 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB25FMYAMDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,717.94 delivery order on August 15, 2025, for the supply of Trulicity 1.5 mg/0.5 ml pen injections, a diabetes medication. This firm fixed-price contract, with an ultimate completion date of August 18, 2025, represents a child delivery order under a larger contract vehicle and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting the contractor's proven capability to fulfill federal medical procurement requirements. This delivery order falls under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.99 billion through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies pharmaceutical products and medical supplies to military and veteran healthcare systems, the Defense Health Agency, and other government healthcare entities. The company's extensive federal contracting portfolio demonstrates consistent success in delivering both brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/15/25 |